SD-Cd59em1Ask-/- |
red blood cell distribution width-coefficient of variation |
control condition (between 56 and 70 days) |
Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9. |
erythrocyte size trait |
both |
56 days-70 days |
6 |
14.2 |
% |
0.82 |
2.0 |
automated hematology analysis |
0.0 |
0 |
|
104626 |
2971 |
LE-Lrrk2em1Sage-/- |
red blood cell distribution width-coefficient of variation |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
60 days
| 4 |
11.0 |
% |
0.3 |
0.6 |
automated hematology analysis |
|
0 |
|
106267 |
3026 |
Crl:LE |
red blood cell distribution width-coefficient of variation |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
30 days
| 4 |
13.4 |
% |
0.16 |
0.32 |
automated hematology analysis |
|
0 |
|
106212 |
3026 |
BDIX/CrCrl |
red blood cell distribution width-coefficient of variation |
DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) |
Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. |
erythrocyte size trait |
male |
92 days
| 10 |
17.0 |
% |
0.22 |
0.7 |
automated hematology analysis |
0.0 |
0 |
MCV, RDW% |
107849 |
3097 |
BDIX/CrCrl |
red blood cell distribution width-coefficient of variation |
DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) |
Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. |
erythrocyte size trait |
male |
71 days
| 10 |
16.9 |
% |
0.22 |
0.7 |
automated hematology analysis |
0.0 |
0 |
MCV, RDW% |
107846 |
3097 |
SD |
red blood cell distribution width-coefficient of variation |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
male |
71 days-85 days |
6 |
11.57 |
% |
0.14 |
0.34 |
unspecified method |
0.0 |
0 |
|
84963 |
1602 |
SD |
red blood cell distribution width-coefficient of variation |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
male |
85 days-99 days |
6 |
11.35 |
% |
0.16 |
0.38 |
unspecified method |
0.0 |
0 |
|
84974 |
1602 |
SD-Fhem1+/- |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
female |
0 days
| 3 |
16.0 |
% |
0.69 |
1.2 |
automated blood analysis |
0.0 |
0 |
|
104916 |
2989 |
SD |
red blood cell distribution width-coefficient of variation |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
male |
71 days-85 days |
6 |
11.87 |
% |
0.18 |
0.44 |
unspecified method |
0.0 |
0 |
|
84966 |
1602 |
SD |
red blood cell distribution width-coefficient of variation |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
female |
71 days-85 days |
6 |
11.13 |
% |
0.35 |
0.85 |
unspecified method |
0.0 |
0 |
|
84972 |
1602 |
SD |
red blood cell distribution width-coefficient of variation |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
male |
71 days-85 days |
6 |
12.35 |
% |
0.24 |
0.59 |
unspecified method |
0.0 |
0 |
|
84964 |
1602 |
SD |
red blood cell distribution width-coefficient of variation |
acetaminophen (1000 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
male |
85 days-99 days |
6 |
11.73 |
% |
0.18 |
0.44 |
unspecified method |
0.0 |
0 |
|
84968 |
1602 |
SD |
red blood cell distribution width-coefficient of variation |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
female |
71 days-85 days |
6 |
12.62 |
% |
0.32 |
0.79 |
unspecified method |
0.0 |
0 |
|
84971 |
1602 |
BDIX/CrCrl |
red blood cell distribution width-coefficient of variation |
DHD/K12/TRb cells (1.5 X 10E6) then sanguinarine (5 mg/kg/d) |
Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. |
erythrocyte size trait |
male |
71 days
| 10 |
16.9 |
% |
0.16 |
0.5 |
automated hematology analysis |
0.0 |
0 |
MCV, RDW% |
107847 |
3097 |
SD-Fhem1+/+ |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
0 days
| 3 |
17.3 |
% |
0.4 |
0.7 |
automated blood analysis |
0.0 |
0 |
|
104913 |
2989 |
SD |
red blood cell distribution width-coefficient of variation |
acetaminophen (250 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
female |
71 days-85 days |
6 |
11.38 |
% |
0.37 |
0.9 |
unspecified method |
0.0 |
0 |
|
84970 |
1602 |
SD-Fhem1+/+ |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
female |
0 days
| 3 |
14.6 |
% |
1.91 |
3.3 |
automated blood analysis |
0.0 |
0 |
|
104914 |
2989 |
SD-Fhem1+/- |
red blood cell distribution width-coefficient of variation |
control condition |
Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429. |
erythrocyte size trait |
male |
0 days
| 3 |
19.6 |
% |
0.81 |
1.4 |
automated blood analysis |
0.0 |
0 |
|
104915 |
2989 |
SD-Cd59em1Ask+/+ |
red blood cell distribution width-coefficient of variation |
control condition (between 56 and 70 days) |
Yao X and Verkman AS, Acta Neuropathol Commun. 2017 Feb 17;5(1):15. doi: 10.1186/s40478-017-0417-9. |
erythrocyte size trait |
both |
56 days-70 days |
6 |
13.3 |
% |
0.94 |
2.3 |
automated hematology analysis |
0.0 |
0 |
|
104625 |
2971 |
Crl:LE |
red blood cell distribution width-coefficient of variation |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
480 days
| 4 |
13.2 |
% |
0.14 |
0.28 |
automated hematology analysis |
|
0 |
|
106320 |
3026 |
LE-Lrrk2em1Sage-/- |
red blood cell distribution width-coefficient of variation |
control condition (for 480 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
480 days
| 4 |
12.2 |
% |
0.04 |
0.08 |
automated hematology analysis |
|
0 |
|
106321 |
3026 |
LE-Lrrk2em1Sage-/- |
red blood cell distribution width-coefficient of variation |
control condition (for 30 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
30 days
| 4 |
13.3 |
% |
0.17 |
0.34 |
automated hematology analysis |
|
0 |
|
106213 |
3026 |
SD |
red blood cell distribution width-coefficient of variation |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
female |
71 days-85 days |
6 |
10.98 |
% |
0.32 |
0.78 |
unspecified method |
0.0 |
0 |
|
84969 |
1602 |
SD |
red blood cell distribution width-coefficient of variation |
acetaminophen (500 mg/kg) (for 28 days) |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
male |
71 days-85 days |
6 |
11.97 |
% |
0.09 |
0.23 |
unspecified method |
0.0 |
0 |
|
84965 |
1602 |
SD |
red blood cell distribution width-coefficient of variation |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
male |
85 days-99 days |
6 |
11.9 |
% |
0.18 |
0.45 |
unspecified method |
0.0 |
0 |
|
84967 |
1602 |
SD |
red blood cell distribution width-coefficient of variation |
control condition |
Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. |
erythrocyte size trait |
female |
85 days-99 days |
6 |
11.32 |
% |
0.24 |
0.59 |
unspecified method |
0.0 |
0 |
|
84973 |
1602 |
Crl:LE |
red blood cell distribution width-coefficient of variation |
control condition (for 60 days) |
Baptista MA, et al., PLoS One. 2013 Nov 14;8(11):e80705. doi: 10.1371/journal.pone.0080705. eCollection 2013. |
erythrocyte size trait |
male |
60 days
| 4 |
11.0 |
% |
0.05 |
0.1 |
automated hematology analysis |
|
0 |
|
106266 |
3026 |
BDIX/CrCrl |
red blood cell distribution width-coefficient of variation |
DHD/K12/TRb cells (1.5 X 10E6) |
Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. |
erythrocyte size trait |
male |
56 days
| 20 |
16.4 |
% |
0.02 |
0.1 |
automated hematology analysis |
0.0 |
0 |
MCV, RDW% |
107845 |
3097 |
BDIX/CrCrl |
red blood cell distribution width-coefficient of variation |
DHD/K12/TRb cells (1.5 X 10E6) then vehicle control condition (1 ml) |
Pica F, etal., Anticancer Drugs. 2012 Jan;23(1):32-42. doi: 10.1097/CAD.0b013e32834a0c8e. |
erythrocyte size trait |
male |
92 days
| 10 |
17.7 |
% |
0.13 |
0.4 |
automated hematology analysis |
0.0 |
0 |
MCV, RDW% |
107848 |
3097 |